PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Keller, P.* ; Mazo, I.* ; Gao, Y.* ; Reddy, V.* ; Caballero, F.* ; Kazer, S.* ; Fu, A.* ; Sun, Y.* ; Miller, D.* ; Gianani, R.* ; Marvin, J.* ; Stephens, B.* ; Beatty, G.* ; Jenkins, R.* ; von Andrian, U.* ; Krappmann, D. ; Mempel, T.*

Reprogramming regulatory T cells (TREG) using a MALT1 inhibitor for cancer therapy.

J. Immunother. Cancer 9, A902-A902 (2021)
Publ. Version/Full Text DOI
Free by publisher
Open Access Green as soon as Postprint is submitted to ZB.
Altmetric
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 2051-1426
e-ISSN 2051-1426
Journal Journal for ImmunoTherapy of Cancer
Quellenangaben Volume: 9, Issue: , Pages: A902-A902 Article Number: , Supplement: ,
Publisher BioMed Central
Publishing Place London
Reviewing status Peer reviewed
Institute(s) Research Unit Signaling and Translation (SAT)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-509800-002
DOI 10.1136/jitc-2021-SITC2021.861
WOS ID WOS:000774877500830
Erfassungsdatum 2022-05-09
[➜Report correction]